Intuitive Surgical, Inc. $ISRG Shares Purchased by Andra AP fonden

Key Points

• Andra AP fonden increased its Intuitive Surgical stake by 63.4% in the second quarter, acquiring 31,720 additional shares for a total holding valued at approximately $32.5 million. Institutional investors collectively own 83.64% of the company.
• Analysts maintain a generally positive outlook, with 22 Buy ratings, eight Holds and one Sell; the stock has a consensus “Moderate Buy” rating and a $508.68 price target, despite several recent target reductions.
• Intuitive Surgical’s latest quarterly results exceeded expectations, with $2.80 in EPS and $2.89 billion in revenue, representing 18.4% year-over-year revenue growth. Meanwhile, insiders sold 12,370 shares worth about $4.9 million over the past three months.

Andra AP fonden grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 63.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 81,770 shares of the medical equipment provider's stock after acquiring an additional 31,720 shares during the period. Andra AP fonden's holdings in Intuitive Surgical were worth $32,518,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the stock. Deutsche Bank AG grew its holdings in shares of Intuitive Surgical by 9.6% during the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider's stock valued at $862,108,000 after purchasing an additional 132,966 shares during the last quarter. Plato Investment Management Ltd bought a new stake in shares of Intuitive Surgical in the 2nd quarter worth approximately $4,315,000. Sycomore Asset Management acquired a new position in Intuitive Surgical during the 4th quarter valued at approximately $10,730,000. Hikari Power Ltd bought a new position in Intuitive Surgical during the 2nd quarter worth $5,619,000. Finally, Xponance LLC increased its position in Intuitive Surgical by 5.3% in the fourth quarter. Xponance LLC now owns 91,787 shares of the medical equipment provider's stock worth $51,984,000 after buying an additional 4,648 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an "outperform" rating for the company in a report on Friday, July 17th. KeyCorp reiterated an "overweight" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. The Goldman Sachs Group set a $558.00 target price on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Royal Bank Of Canada decreased their target price on shares of Intuitive Surgical from $650.00 to $600.00 and set an "outperform" rating for the company in a research report on Monday, July 13th. Finally, Raymond James Financial restated an "outperform" rating and issued a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $508.68.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the company's stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $375.57, for a total transaction of $28,918.89. Following the completion of the sale, the executive vice president directly owned 881 shares of the company's stock, valued at approximately $330,877.17. This represents a 8.04% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy Ladd sold 400 shares of Intuitive Surgical stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the director directly owned 251 shares in the company, valued at approximately $95,129. This trade represents a 61.44% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 12,370 shares of company stock worth $4,891,989 in the last three months. Insiders own 0.60% of the company's stock.

Intuitive Surgical Stock Down 0.0%

NASDAQ:ISRG traded down $0.17 during trading hours on Tuesday, reaching $401.48. 615,827 shares of the company's stock were exchanged, compared to its average volume of 2,450,544. The company has a market capitalization of $141.84 billion, a P/E ratio of 46.01, a price-to-earnings-growth ratio of 2.97 and a beta of 1.47. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The business's 50-day simple moving average is $372.58 and its two-hundred day simple moving average is $418.49.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the firm earned $1.81 EPS. The company's quarterly revenue was up 18.4% compared to the same quarter last year. As a group, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc is a medical technology company that develops and manufactures robotic-assisted surgical systems and related products. Its technology is designed to support surgeons during minimally invasive procedures by providing enhanced visualization, instrument control and dexterity.

The company's principal product is the da Vinci Surgical System, which is used across a range of specialties, including general surgery, urology, gynecology, cardiothoracic surgery and other procedures.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.